Journal Report

INTERNATIONAL JOURNAL OF DERMATOLOGY

Download PDF
Journal Information
Journal Title
INTERNATIONAL JOURNAL OF DERMATOLOGY
Publisher
WILEY
ISSN
0011-9059
E-ISSN
1365-4632
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Clinical Interpretation of Ultraviolet and Sub Ultraviolet Dermoscopy for Facial Pigmented Lesions
Dika Emi, Lambertini Martina
2026-11-11
DOI: 10.1111/ijd.70787
Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study
Matteo Bianco, Alessandra Narcisi, Luciano Ibba et al.
2026-11-11
DOI: 10.1111/ijd.70789
Diagnostic Features of Cutaneous Micromelanoma (≤ 6 mm): A Systematic Review and Meta‐Analysis
Jakub Żółkiewicz, Martina Cavicchi, Krzysztof Pastuszak et al.
2026-11-11
DOI: 10.1111/ijd.70775
Onychogryphosis Severity Score: A Proposed Clinical Severity Instrument and Its Clinical Correlates
Jeongwu Seong, Jungsoo Lee, Kihyuk Shin et al.
2026-11-10
DOI: 10.1111/ijd.70783
Barriers to Dermatologic Care Among Insured Refugees: A Retrospective Cohort Analysis
Hadeel Al‐Sahli, Jordan Jafarnia, Priscilla L. Blackwell et al.
2026-11-10
DOI: 10.1111/ijd.70784
Tapinarof Cream‐Associated Allergic Contact Dermatitis With Photo‐Exposed Distribution: A Case Report
Nana Ebi, Kazuya Goto, Toshiya Miyake et al.
2026-11-10
DOI: 10.1111/ijd.70786
Beyond the “To Test or Not to Test” Dilemma: Clinical Investigations for Food Allergy in Atopic Dermatitis
Krisztian Gaspar
2026-11-9
DOI: 10.1111/ijd.70774
Issue Information
2026-11-8 Vol. 65 Issue 12 Pages 2449-2450
DOI: 10.1111/ijd.70780
Ruxolitinib for Refractory Foreign‐Body Granulomas After Cosmetic Filler Injections
Léna Ronjat, Jean‐Paul Vernant, Thierry de Revel et al.
2026-11-5
DOI: 10.1111/ijd.70777
Patient‐Reported Outcomes are Absent From Measurement of Cutaneous Immune‐Related Adverse Events Across Checkpoint Inhibitor Trials
David X. Zheng, Melissa A. Levoska
2026-11-5
DOI: 10.1111/ijd.70773
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 13, 2026 08:39